Emerging Innovation

Devices developed by CreatiVasc Medical bring needed innovation to the growing hemodialysis market; including devices that protect the integrity of vascular access, Arteriovenous (AV) Fistulas and Arteriovenous (AV) Grafts. The CreatiVasc product line reduces complications associated with vascular access, thereby improving patient care and reducing overall costs associated with hemodialysis.

The target market is characterized by patients with an inability of the kidneys to perform the critical functions of excreting wastes, concentrating urine and regulating electrolytes. Unfortunately, There has been an increase in incidence of End Stage Renal Disease (ESRD), both in the United States and around the world, and is forecasted to expand at a minimum rate of 5-7% over the next decade due to demographics of an aging population and increases in the incidence rates of diabetes mellitus, obesity, and hypertension.

At CreatiVasc Medical, our mission is to: “Deliver a stream of innovative, easy-to-use vascular technologies that address the universal problems of kidney dialysis connectivity and dramatically improve dialysis patients’ quality of life”.

The company has already launched our phased-introduction plan for its first 4 devices. This phased introduction is designed to keep our focus on developing emerging innovations into a field in need of advancement. Our company’s founder, Dr David Cull, has been featured on The History Channel’s, Modern Marvels. He was one of five finalists in the 2006 Invent Now Challenge for his work with the Hemoaccess Valve System.

Please visit the CreatiVasc website to see our next exciting developing in the vascular access field